An Exploratory Study of the Safety and Efficacy of BOTOX for the Treatment of Premature Ejaculation

Trial Profile

An Exploratory Study of the Safety and Efficacy of BOTOX for the Treatment of Premature Ejaculation

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2017

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Premature ejaculation
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 18 Sep 2017 Status changed from recruiting to discontinued.
    • 03 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 03 Oct 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top